SG11201702035WA - Nutritional supplements containing a peptide component and uses thereof - Google Patents
Nutritional supplements containing a peptide component and uses thereofInfo
- Publication number
- SG11201702035WA SG11201702035WA SG11201702035WA SG11201702035WA SG11201702035WA SG 11201702035W A SG11201702035W A SG 11201702035WA SG 11201702035W A SG11201702035W A SG 11201702035WA SG 11201702035W A SG11201702035W A SG 11201702035WA SG 11201702035W A SG11201702035W A SG 11201702035WA
- Authority
- SG
- Singapore
- Prior art keywords
- nutritional supplements
- peptide component
- supplements containing
- peptide
- component
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/535,241 US10251928B2 (en) | 2014-11-06 | 2014-11-06 | Nutritional supplements containing a peptide component and uses thereof |
| PCT/US2015/054383 WO2016073126A1 (en) | 2014-11-06 | 2015-10-07 | Nutritional supplements containing a peptide component and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201702035WA true SG11201702035WA (en) | 2017-04-27 |
Family
ID=54337903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201702035WA SG11201702035WA (en) | 2014-11-06 | 2015-10-07 | Nutritional supplements containing a peptide component and uses thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10251928B2 (en) |
| EP (1) | EP3214953A1 (en) |
| CN (1) | CN107073071A (en) |
| AR (1) | AR102545A1 (en) |
| AU (1) | AU2015343607A1 (en) |
| BR (1) | BR112017008776A2 (en) |
| CA (1) | CA2962133A1 (en) |
| MX (1) | MX2017005776A (en) |
| PH (1) | PH12017500740A1 (en) |
| SG (1) | SG11201702035WA (en) |
| TW (1) | TW201628509A (en) |
| WO (1) | WO2016073126A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180153951A1 (en) * | 2016-12-05 | 2018-06-07 | Mead Johnson Nutrition Company | Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction |
| EP3612570A4 (en) | 2017-04-17 | 2021-01-13 | The University of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| EP1961312A3 (en) | 1991-01-24 | 2010-03-31 | Martek Biosciences Corporation | Microbial oil mixture and uses thereof |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| GB9310472D0 (en) * | 1993-05-20 | 1993-07-07 | Univ Warwick | Phenylalanine-free protein and dna coding thereof |
| US6884294B2 (en) | 2001-04-16 | 2005-04-26 | Tokyo Electron Limited | Coating film forming method and apparatus |
| TW200412942A (en) | 2002-08-06 | 2004-08-01 | Abbott Lab | Appetite control method |
| US20040132819A1 (en) | 2002-08-06 | 2004-07-08 | Nancy Auestad | Appetite control method |
| WO2004069265A1 (en) | 2003-02-07 | 2004-08-19 | Campina B.V. | Use of tryptophan rich peptides |
| WO2005063050A1 (en) | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Method of increasing lean body mass and reducing body fat mass in infants |
| JP2008509073A (en) * | 2004-03-01 | 2008-03-27 | ペプテラ ファーマスーティカルズ エルティーディー． | Casein-derived peptides and their therapeutic use |
| US20060286208A1 (en) * | 2005-06-01 | 2006-12-21 | Nagendra Rangavajla | Methods for producing protein partial hydrolysates and infant formulas containing the same |
| US7618669B2 (en) | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| CN102894371A (en) | 2005-07-01 | 2013-01-30 | 努特里希亚公司 | Infant nutrition with hydrolised proteins |
| WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
| ES2537080T3 (en) | 2005-12-23 | 2015-06-02 | N.V. Nutricia | Composition comprising polyunsaturated fatty acids, proteins and manganese and / or molybdenum to improve the composition of cell membranes |
| CA2642969A1 (en) | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara for increasing lean muscle mass and decreasing adipose tissue in infants |
| EP1993530A2 (en) | 2006-02-28 | 2008-11-26 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for regulating gene expression |
| WO2007100562A2 (en) | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for reducing triglyceride levels |
| EP2003991A1 (en) | 2006-04-12 | 2008-12-24 | DSM IP Assets B.V. | Novel nutraceutical compositions |
| JP5735734B2 (en) | 2009-04-16 | 2015-06-17 | 雪印メグミルク株式会社 | Lipid metabolism improver |
| ES2555032T3 (en) | 2010-01-19 | 2015-12-28 | Mjn U.S. Holdings Llc | Nutritional compensation for western type diet |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| US9345727B2 (en) * | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
-
2014
- 2014-11-06 US US14/535,241 patent/US10251928B2/en active Active
-
2015
- 2015-10-07 CA CA2962133A patent/CA2962133A1/en not_active Abandoned
- 2015-10-07 BR BR112017008776A patent/BR112017008776A2/en not_active Application Discontinuation
- 2015-10-07 EP EP15784224.6A patent/EP3214953A1/en not_active Withdrawn
- 2015-10-07 WO PCT/US2015/054383 patent/WO2016073126A1/en active Application Filing
- 2015-10-07 SG SG11201702035WA patent/SG11201702035WA/en unknown
- 2015-10-07 CN CN201580060368.XA patent/CN107073071A/en active Pending
- 2015-10-07 AU AU2015343607A patent/AU2015343607A1/en not_active Abandoned
- 2015-10-07 MX MX2017005776A patent/MX2017005776A/en unknown
- 2015-10-15 TW TW104133880A patent/TW201628509A/en unknown
- 2015-11-05 AR ARP150103591A patent/AR102545A1/en unknown
-
2017
- 2017-04-21 PH PH12017500740A patent/PH12017500740A1/en unknown
-
2019
- 2019-04-08 US US16/377,667 patent/US10933114B2/en active Active
- 2019-04-08 US US16/377,594 patent/US11077166B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11077166B2 (en) | 2021-08-03 |
| US20190240283A1 (en) | 2019-08-08 |
| AU2015343607A1 (en) | 2017-03-30 |
| WO2016073126A1 (en) | 2016-05-12 |
| CN107073071A (en) | 2017-08-18 |
| PH12017500740A1 (en) | 2017-10-09 |
| TW201628509A (en) | 2016-08-16 |
| MX2017005776A (en) | 2017-07-28 |
| US20210244787A9 (en) | 2021-08-12 |
| CA2962133A1 (en) | 2016-05-12 |
| EP3214953A1 (en) | 2017-09-13 |
| BR112017008776A2 (en) | 2018-05-15 |
| US20190224273A1 (en) | 2019-07-25 |
| AR102545A1 (en) | 2017-03-08 |
| US10933114B2 (en) | 2021-03-02 |
| US20160129071A1 (en) | 2016-05-12 |
| US10251928B2 (en) | 2019-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290084A (en) | Fast-acting plant-based medicinal compounds and nutritional supplements | |
| IL249186B (en) | Anti-cd20 glycoantibodies and uses thereof | |
| EP3212006A4 (en) | Nutritional supplements | |
| IL267018A (en) | Fast-acting plant-based medicinal compounds and nutritional supplements | |
| IL267831A (en) | Medicinal compounds and nutritional supplements | |
| SG11201609967TA (en) | Potato based protein mixtures and nutritional compositions comprising potato protein | |
| GB201403528D0 (en) | A nutritional supplement | |
| IL247464A0 (en) | Nutritional supplement powder | |
| SG11201803125XA (en) | Nutritional compositions containing butyrate and uses thereof | |
| HK1216591A1 (en) | Nutritional composition containing a peptide component and uses thereof | |
| SG11201702036QA (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | |
| EP3128849A4 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
| PL3013304T3 (en) | Container and kit for providing parenteral nutrition | |
| GB201602804D0 (en) | Dietary supplement | |
| SG11201700058QA (en) | Dilute-type nutritional composition | |
| SG11201702035WA (en) | Nutritional supplements containing a peptide component and uses thereof | |
| GB201400293D0 (en) | Nutritional composition | |
| IL251289B (en) | Novel peptide derivatives and uses thereof | |
| ZA201807868B (en) | Nutritional supplements | |
| IL260164A (en) | High protein nutritional product | |
| HK1231331A1 (en) | Nutritional compositions containing ceramide | |
| SG11201610918RA (en) | Peptides and uses thereof | |
| GB201401673D0 (en) | Esculentin-2CHa peptide and analogues thereof | |
| ZA201801218B (en) | Medicament and nutritional supplement | |
| GB201416638D0 (en) | Nutritional supplement |